In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics Against

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2021 Jan 27

PMID 33498622

Citations 8

Authors

Patricia Esteban

Sergio Redrado

Laura Comas

M Pilar Domingo

M Isabel Millan-Lou

Cristina Seral

Sonia Algarate

Concha Lopez

Antonio Rezusta

Julian Pardo

Maykel Arias

Eva M Galvez

Affiliations

Soon will be listed here.

Abstract

Multidrug-resistant bacteria such as methicillin-resistant (MRSA) is one of the major causes of hospital-acquired and community infections and pose a challenge to the human health care system. Therefore, it is important to find new drugs that show activity against these bacteria, both in monotherapy and in combination with other antimicrobial drugs. Gliotoxin (GT) is a mycotoxin produced by and other fungi of the genus. Some evidence suggests that GT shows antimicrobial activity against in vitro, albeit its efficacy against multidrug-resistant strains such asMRSA or vancomycin-intermediate (VISA) strainsis not known. This work aimedto evaluate the antibiotic efficacy of GT as monotherapy or in combination with other therapeutics against MRSA in vitro and in vivo using a infection model.

Citing Articles

Potentiality of Antibacterial Gels for the Prophylactic Coating of Hernia Repair Prosthetic Materials.

Perez-Kohler B, Benito-Martinez S, Rivas-Santos C, Gomez-Gil V, Garcia-Moreno F, Pascual G Gels. 2024; 10(11).

PMID: 39590043 PMC: 11593720. DOI: 10.3390/gels10110687.

Loratadine Combats Methicillin-Resistant by Modulating Virulence, Antibiotic Resistance, and Biofilm Genes.

Viering B, Balogh H, Cox C, Kirpekar O, Akers A, Federico V ACS Infect Dis. 2023; 10(1):232-250.

PMID: 38153409 PMC: 10788911. DOI: 10.1021/acsinfecdis.3c00616.

Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion.

Downes S, Owens R, Walshe K, Fitzpatrick D, Dorey A, Jones G Sci Rep. 2023; 13(1):16156.

PMID: 37758814 PMC: 10533825. DOI: 10.1038/s41598-023-43300-w.

Gliotoxin and related metabolites as zinc chelators: implications and exploitation to overcome antimicrobial resistance.

Downes S, Doyle S, Jones G, Owens R Essays Biochem. 2023; 67(5):769-780.

PMID: 36876884 PMC: 10500201. DOI: 10.1042/EBC20220222.

Lipo-Chitooligosaccharides Induce Specialized Fungal Metabolite Profiles That Modulate Bacterial Growth.

Rush T, Tannous J, Lane M, Gopalakrishnan Meena M, Carrell A, Golan J mSystems. 2022; 7(6):e0105222.

PMID: 36453934 PMC: 9764981. DOI: 10.1128/msystems.01052-22.

References

Howden B, Davies J, Johnson P, Stinear T, Grayson M . Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23(1):99-139. PMC: 2806658. DOI: 10.1128/CMR.00042-09. View

Roberts S, Chambers S . Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J. 2005; 35 Suppl 2:S97-105. DOI: 10.1111/j.1444-0903.2005.00983.x. View

Oliveira D, Borges A, Simoes M . Toxins and Their Molecular Activity in Infectious Diseases. Toxins (Basel). 2018; 10(6). PMC: 6024779. DOI: 10.3390/toxins10060252. View

Li X, Kim S, Nam K, Kang J, Choi H, Son B . A new antibacterial dioxopiperazine alkaloid related to gliotoxin from a marine isolate of the fungus Pseudallescheria. J Antibiot (Tokyo). 2006; 59(4):248-50. DOI: 10.1038/ja.2006.35. View

Gardiner D, Waring P, Howlett B . The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology (Reading). 2005; 151(Pt 4):1021-1032. DOI: 10.1099/mic.0.27847-0. View

Murdoch D, Corey G, Hoen B, Miro J, Fowler Jr V, Bayer A . Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169(5):463-73. PMC: 3625651. DOI: 10.1001/archinternmed.2008.603. View

Gould D, Chamberlaine A . Staphylococcus aureus: a review of the literature. J Clin Nurs. 1995; 4(1):5-12. DOI: 10.1111/j.1365-2702.1995.tb00004.x. View

Pardo J, Urban C, M Galvez E, Ekert P, Muller U, Kwon-Chung J . The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol. 2006; 174(4):509-19. PMC: 2064257. DOI: 10.1083/jcb.200604044. View

Lakhundi S, Zhang K . Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology. Clin Microbiol Rev. 2018; 31(4). PMC: 6148192. DOI: 10.1128/CMR.00020-18. View

10.

Beanan M, Strome S . Characterization of a germ-line proliferation mutation in C. elegans. Development. 1992; 116(3):755-66. DOI: 10.1242/dev.116.3.755. View

11.

Linares J . The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect. 2001; 7 Suppl 4:8-15. DOI: 10.1046/j.1469-0691.2001.00054.x. View

12.

Park K, Kim E, Kim H, Park S, Bang K, Park H . Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. J Antimicrob Chemother. 2012; 67(8):1843-9. DOI: 10.1093/jac/dks131. View

13.

Blondeau J . New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Vet Dermatol. 2010; 20(5-6):383-96. DOI: 10.1111/j.1365-3164.2009.00856.x. View

14.

Reece E, Doyle S, Greally P, Renwick J, McClean S . Inhibits in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway. Front Microbiol. 2018; 9:1205. PMC: 5996130. DOI: 10.3389/fmicb.2018.01205. View

15.

Sahoo K, Sahoo S, Marrone G, Pathak A, Stalsby Lundborg C, Tamhankar A . Climatic factors and community - associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections - a time-series analysis study. Int J Environ Res Public Health. 2014; 11(9):8996-9007. PMC: 4199002. DOI: 10.3390/ijerph110908996. View

16.

Odds F . Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003; 52(1):1. DOI: 10.1093/jac/dkg301. View

17.

Tong S, Davis J, Eichenberger E, Holland T, Fowler Jr V . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3):603-61. PMC: 4451395. DOI: 10.1128/CMR.00134-14. View

18.

Golden M, Hahm S, Elessar R, Saksonov S, Steinberg J . DNA damage by gliotoxin from Aspergillus fumigatus. An occupational and environmental propagule: adduct detection as measured by 32P DNA radiolabelling and two-dimensional thin-layer chromatography. Mycoses. 1998; 41(3-4):97-104. DOI: 10.1111/j.1439-0507.1998.tb00308.x. View

19.

McGuinness W, Malachowa N, DeLeo F . Vancomycin Resistance in  . Yale J Biol Med. 2017; 90(2):269-281. PMC: 5482303. View

20.

Fridkin S, Hageman J, McDougal L, Mohammed J, Jarvis W, Perl T . Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis. 2003; 36(4):429-39. DOI: 10.1086/346207. View